Views & Analysis High-value, high-cost drugs: how to pay for them Experts call for urgent development of new drug funding mechanisms.
Views & Analysis Tunnah’s musings: Hope over hype for pharma in patient centr... Three areas where the pharma industry will advance in 2017 as it looks beyond the hype.
Events Partner Content Making Pharmaceuticals 25 & 26 April 2017 Exhibition & Conference for Pharma Professionals
Views & Analysis Unified systems mean faster clinical trials Inefficient processes, legacy infrastructure and a silo culture are slowing access to critical trial data.
Views & Analysis How can pharma help NHS improve mental health services? Sustainability and Transformation Plans present an opportunity for pharma to support research into mental health conditions.
Views & Analysis From treatment to technology: a personal journey William King, founder and executive chairman of Zephyr Health, on using predictive insights for business transformation.
News ADARx, Trex, and Retension take aim at IPOs The appetite among biotechs for IPOs shows no signs of being satisfied, with three more – ADARx, TRex, and Retension – making their intentions known.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
